Cytotoxic Drug Handlers—Monitoring in the Occupational Health Setting

American Society of Hospital Pharmacists. (1990). Technical assistance bulletin on handling cytotoxic and hazardous drugs. American Journal of Hospital Pharmacists, 47, 1033–1049.

Doll D.C. (1989). Aerosolized pentamidine. Lancet, ii, 1284–1285.

Ensslin A.S. , Stoll Y. , Pethran A. , Pfaller A. , Rummelt H. , & Fruhmann G. (1994). Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs. Occupational Environmental Medicine, 51(4), 229–233.

McDiarmid M.A. (1990). Medical surveillance for antineoplastic-drug handlers. American Journal of Hospital Pharmacists, 47(5), 1061–1066.

Occupational Safety and Health Administration. (1986, January 29). Guidelines for cytotoxic (anti-neoplastic) drugs (Directives Publication No. 8-1.1). Washington, DC: Office of Occupational Medicine.

Occupational Safety and Health Administration. (1999). Controlling occupation exposure to hazardous drugs. OSHA Technical Manual (TED 1-0.15A), Section VI, Chapter 2, 1–35.

Occupational Safety and Health Administration. (2001). Occupational safety and health standards: Access to employee exposure and medical records, 1910.1020, 29(6), 1–29.

Sessink P.J. , & Bos R.P. (1999). Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug Safety, 20(4), 347–359.

Sotaniemie E.A. , Sutinen S. , Arranto A.J. , Sutinen S. , Sotaniemi K.A. , Lehtola J. , & Pelkonen R. (1983). Liver damage in nurses handling cytostatic agents. Acta Medica Scandinavica, 214(3), 181–189.